Stocks and Investing Stocks and Investing
Thu, November 18, 2021
Wed, November 17, 2021
Tue, November 16, 2021
Mon, November 15, 2021

Matthew Harrison Maintained (AKRO) at Hold with Increased Target to $29 on, Nov 15th, 2021


Published on 2024-10-27 18:38:46 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Akero Therapeutics, Inc." (AKRO) at Hold with Increased Target from $27 to $29 on, Nov 15th, 2021.

Matthew has made no other calls on AKRO in the last 4 months.



There is 1 other peer that has a rating on AKRO. Out of the 1 peers that are also analyzing AKRO, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Aspen Mori of "B of A Securities" Initiated at Strong Buy and Held Target at $40 on, Friday, September 10th, 2021